Winton Group LTD G1 Therapeutics, Inc. Transaction History

Winton Group LTD

  • $1.31 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020
SELL
$9.07 - $26.32 $359,852 - $1.04 Million
-39,675 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$20.54 - $31.0 $814,924 - $1.23 Million
39,675 New
39,675 $1.05 Million
Q4 2018

Feb 05, 2019
SELL
$16.51 - $51.33 $68,747 - $213,738
-4,164 Closed
0 $0
Q3 2018

Nov 02, 2018
BUY
$43.15 - $67.97 $179,676 - $283,027
4,164 New
4,164 $0

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email